The ROE as of November 2024 (TTM) for Portage Biotech Inc. (PRTG) is -267.72%

According to Portage Biotech Inc.’s latest financial reports and current stock price. The company's current ROE is -267.72%. This represents a change of 31.33% compared to the average of -203.86% of the last 4 quarters.

Portage Biotech Inc. (PRTG) Historical ROE (quarterly & annually)

How has PRTG ROE performed in the past?

The mean historical ROE of Portage Biotech Inc. over the last ten years is -91.27%. The current -267.72% ROE has changed 193.34% with respect to the historical average. Over the past ten years (40 quarters), PRTG's ROE was at its highest in in the March 2018 quarter at 1.30%. The ROE was at its lowest in in the March 2024 quarter at -618.82%.

Portage Biotech Inc. (PRTG) ROE by Quarter and Year

Discovering the peaks and valleys of Portage Biotech Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Portage Biotech Inc. (PRTG) Average ROE

How has PRTG ROE performed in the past?

The current ROE of Portage Biotech Inc. (PRTG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Portage Biotech Inc. (PRTG) ROE vs. Peers

How is PRTG’s ROE compared to its peers?

Portage Biotech Inc.’s ROE is greater than Amylyx Pharmaceuticals, Inc. (-85.39%), greater than Karuna Therapeutics, Inc. (-25.23%), greater than Blueprint Medicines Corporation (-47.66%), greater than Arvinas, Inc. (-50.26%), greater than Aerovate Therapeutics, Inc. (-90.19%), greater than Eliem Therapeutics, Inc. (-47.03%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), greater than Cue Biopharma, Inc. (-156.38%), greater than Decibel Therapeutics, Inc. (-56.38%), greater than Keros Therapeutics, Inc. (-41.74%), greater than Janux Therapeutics, Inc. (-10.46%), less than Fennec Pharmaceuticals Inc. (31.99%), greater than Edgewise Therapeutics, Inc. (-26.83%), less than Harmony Biosciences Holdings, Inc. (23.16%), greater than Lineage Cell Therapeutics, Inc. (-29.91%), less than MAIA Biotechnology, Inc. (20.47%), less than Armata Pharmaceuticals, Inc. (89.12%), greater than Frequency Therapeutics, Inc. (-54.56%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Acumen Pharmaceuticals, Inc. (-32.99%), greater than X4 Pharmaceuticals, Inc. (-32.51%), greater than Inozyme Pharma, Inc. (-88.42%), greater than VectivBio Holding AG (-56.92%),

Build a custom stock screener for Portage Biotech Inc. (PRTG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Portage Biotech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Portage Biotech Inc. (PRTG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Portage Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.